Long-term subcutaneous recombinant interleukin-2 as maintenance therapy: biological effects and clinical implications.

Guida, M

Long-term subcutaneous recombinant interleukin-2 as maintenance therapy: biological effects and clinical implications. [electronic resource] - Cancer biotherapy 1995 - 195-203 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

1062-8401

10.1089/cbr.1995.10.195 doi


Aged
Combined Modality Therapy
Female
Humans
Injections, Subcutaneous
Interleukin-2--therapeutic use
Male
Middle Aged
Neoplasms--immunology
Prospective Studies
Recombinant Proteins--therapeutic use
Remission Induction